Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. immune modulation
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books

Refine by
Date

  • Older

Immune Modulation Articles & Analysis

34 news found

Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research

Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research

Recent studies have also revealed CAFs' crucial role in modulating the immune system. Targeting intervention by altering CAF numbers, subtypes or functional characteristics is emerging as a novel approach to enhancing the efficacy of cancer treatment. ...

ByCD Bioparticles


Alfa Chemistry Expands Portfolio with High-Purity Marine and Plant-Derived Bioactive Peptides

Alfa Chemistry Expands Portfolio with High-Purity Marine and Plant-Derived Bioactive Peptides

Marine Fish Oligopeptide: These very short chains, sourced from fish, are prized for excellent absorption and potential bioactive properties relevant to cardiovascular health, immune function, and tissue repair. Oyster Peptide: Rich in minerals like zinc and unique amino acids, oyster peptides are explored for their potential role in supporting immune function, ...

ByAlfa Chemistry


Creative Biostructure Expands Its Offerings for Exosomes Isolated from Stem Cell Lines

Creative Biostructure Expands Its Offerings for Exosomes Isolated from Stem Cell Lines

Creative Biostructure's expanded catalog now features exosomes isolated from a variety of stem cell sources, including: l Mesenchymal Stem Cells (MSCs): Known for their ability to differentiate into multiple cell types, MSC-derived exosomes are instrumental in tissue repair and immune modulation. l Human Umbilical Cord Mesenchymal Stem Cells (hUCMSCs): These ...

ByCreative Biostructure


Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...

BySCIREQ - an emka TECHNOLOGIES Company


Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

Lectins, a class of carbohydrate-binding proteins, hold immense significance in the scientific realm due to their diverse biological functions, encompassing cell adhesion, signal transduction, and immune modulation. Their versatility has propelled their adoption in various research pursuits, including the exploration of cancer, inflammatory processes, and ...

ByCreative BioMart


CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

Autoimmune Diseases: Antibodies are designed to modulate the immune response in conditions like rheumatoid arthritis and multiple sclerosis. 3. ...

ByCD ComputaBio


Creative Enzymes Unveils a Diverse Range of Premium Extracts for Various Applications

Creative Enzymes Unveils a Diverse Range of Premium Extracts for Various Applications

Mushroom Extracts: Creative Enzymes recognizes the timeless health benefits of mushrooms and offers a range of Mushroom Extracts that encapsulate their remarkable properties. Focusing on immune modulation and antioxidants, these extracts have found their place in dietary supplements and functional foods. ...

ByCreative Enzymes


Creative Enzymes Introduces a Range of Lactobacillus Strains with Enhanced Benefits

Creative Enzymes Introduces a Range of Lactobacillus Strains with Enhanced Benefits

In recent years, extensive research has emphasized the critical role of gut health in maintaining a balanced immune system and overall vitality. Consequently, the demand for effective probiotic solutions has skyrocketed. ...

ByCreative Enzymes


Announcing the Release of MiXCR 4.0, a Powerful Tool for Immunome Profiling

Announcing the Release of MiXCR 4.0, a Powerful Tool for Immunome Profiling

MiXCR 4.0 is enhanced software for analysis of genomics data and building a comprehensive picture of the immune response. Leading pharmaceutical research and development (R&D) teams can leverage MiXCR 4.0 for drug discovery pipelines, and for analyzing DNA sequencing data unraveling genomic information about antibodies, T-cell, and B-cell receptors. ...

ByMi Laboratories


A Vital Training Opportunity for CGT Manufacturing - A Global Partnership with ISCT & CMaT

A Vital Training Opportunity for CGT Manufacturing - A Global Partnership with ISCT & CMaT

PROGRAM FORMAT Asynchronous lectures composed of Theory and Application components 1 LIVE Expert Panel Discussion and Q&A session per module A certificate of completion is attainable for each module upon completion of the module assessment Program Modules Module 1: Stem Cell & ...

ByCell Manufacturing Technologies (CMaT)


Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Phase 3 ECOSPOR III Study of SER-109 Data Encore Cancer patients are at greater risk of developing rCDI and tend to have worse outcomes, due to their weakened immune system and frequent antibiotics exposure.i Encore data from the completed double-blind, randomized, placebo-controlled Phase 3 ECOSPOR III trial (NCT03183128) show that the investigational microbiome therapeutic ...

BySeres Therapeutics, Inc.


Seres Therapeutics Presents Preclinical Research on Investigational Microbiome Therapeutic SER-155 at the 2022 European Bone Marrow Transplantation Annual Meeting

Seres Therapeutics Presents Preclinical Research on Investigational Microbiome Therapeutic SER-155 at the 2022 European Bone Marrow Transplantation Annual Meeting

Across a variety of preclinical models, SER-155 appears to work by reducing gastrointestinal (GI) inflammation, fortifying the protective GI lining, and promoting immune cell balance in the gut. In cultured human cells designed to mimic the lining of the intestines, SER-155 protected the barrier between the colon and invading pathogens from inflammatory damage. ...

BySeres Therapeutics, Inc.


BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome

BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome

Artificial tears with demulcents can retain surface moisture and immune modulators can help to control inflammation, allowing the body’s natural healing processes to repair damage. ...

ByBRIM Biotechnology, Inc.


Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

The SER-155 composition aims to decrease the colonization and translocation of antibiotic-resistant bacteria in the gastrointestinal tract to decrease the incidence of bloodstream infections and additionally to modulate host immune responses to decrease GvHD. In addition to SER-109, SER-155 represents Seres’ second active development program in its ...

BySeres Therapeutics, Inc.


Report On Activities For The Quarter Ended 31 March 2022

Report On Activities For The Quarter Ended 31 March 2022

Viroporins are virus-encoded proteins that are central to establishing and maintaining infections through modulation of the body's immune system. BIT225 is Biotron's lead antiviral, clinical stage, investigational, orally-dosed small molecule drug that has been evaluated in nine clinical trials involving healthy volunteers, patients with HIV-1 infection, patients ...

ByBiotron Limited


Jubilant Therapeutics Inc. Doses First Patient in Phase I/II Trial Evaluating JBI-802, dual inhibitor of LSD1 and HDAC6, in patients with advanced solid tumors

Jubilant Therapeutics Inc. Doses First Patient in Phase I/II Trial Evaluating JBI-802, dual inhibitor of LSD1 and HDAC6, in patients with advanced solid tumors

” Syed Kazmi, Chief Executive Officer, Jubilant Therapeutics Inc. said, “JBI-802, effectively modulates two validated oncology targets with similar affinity and quick on/off exposure kinetics, leading to synergistic anti-tumour activity with a reduced risk of thrombocytopenia. ...

ByJubilant Therapeutics Inc.


NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center

NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center

(Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a preclinical research collaboration with Columbia University Irving Medical Center’s (CUIMC) Herbert Irving Comprehensive Cancer Center (HICCC). ...

ByNexImmune, Inc.


NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation

NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation

Combining Zephyr’s proprietary artificial intelligence (AI) and algorithmic technology with NexImmune’s Artificial Immune Modulation (AIM) nanoparticle technology, the collaboration will seek to identify and validate optimal antigens and antigen cocktails for the development of potential new therapeutics in solid and hematological cancers. ...

ByNexImmune, Inc.


NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center

NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center

(Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a research and evaluation collaboration with The Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute designated Comprehensive Cancer Center ...

ByNexImmune, Inc.


AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Cancers Symposium

AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Cancers Symposium

The rationale for a combination therapy of tivozanib plus durvalumab to treat HCC draws on the potential synergistic mechanisms of tivozanib and durvalumab to remove inhibition of the immune response that mediates antitumor activity. The selectivity and favorable tolerability of the VEGFR TKI tivozanib may allow it to be used as a combination therapy with an ...

ByAVEO Pharmaceuticals, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT